Amicogen Inc
092040
Company Profile
Business description
Amicogen Inc is an industrial biotechnology company operating in Korea. It is engaged in the development, production, and distribution of enzymes, bio-new materials, and healthcare food. The company's product portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP), and protein A chromatography resins.
Contact
1259-64, Dongbu-ro
Gyeongsangnam-do
Jinseong-myeon660-852
KORT: +82 557596161
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
238
Stocks News & Analysis
stocks
ASX share undervalued as margins expected to rebound
This ASX share remains overlooked despite a strong outlook.
stocks
Cheap retail REIT with an attractive yield
Lower consumer spending unlikely to buckle this retail REIT.
stocks
Expanding store network for ASX listed retailer
Sales growth but lack of margin expansion due to competition.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,185.90 | 70.20 | 0.77% |
| CAC 40 | 8,430.79 | 16.48 | -0.20% |
| DAX 40 | 24,934.67 | 24.26 | 0.10% |
| Dow JONES (US) | 51,935.77 | 63.90 | -0.12% |
| FTSE 100 | 10,508.61 | 14.40 | 0.14% |
| HKSE | 24,312.16 | 181.79 | -0.74% |
| NASDAQ | 26,266.54 | 109.80 | -0.42% |
| Nikkei 225 | 69,902.25 | 497.75 | 0.72% |
| NZX 50 Index | 13,392.98 | 33.15 | -0.25% |
| S&P 500 | 7,479.19 | 32.16 | -0.43% |
| S&P/ASX 200 | 8,966.30 | 65.50 | 0.74% |
| SSE Composite Index | 4,108.08 | 16.18 | 0.40% |